CINVANTI (APREPITANT) INJECTABLE EMULSION
Live / Registered — Registered (as of 10 Dec 2019)
What this means for you
Registered since 10 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87893278
- Registration number
- 5932962
- Mark type
- Design + words
- Filed
- 25 Apr 2018
- Published for opposition
- 25 Sept 2018
- Registered
- 10 Dec 2019
- Attorney of record
- Beth M. Goldman
Goods and services
- Class 005 — Pharmaceuticals: Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
Owner
- Heron Therapeutics, Inc., San Diego, CA, US
- Heron Therapeutics, Inc., San Diego, CA, US
- Heron Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 10 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Aug 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 10 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Oct 2019 — USE AMENDMENT FILED
- 29 Oct 2019 — SOU EXTENSION 2 GRANTED
- 24 Oct 2019 — SOU EXTENSION 2 FILED
- 29 Oct 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Oct 2019 — SOU TEAS EXTENSION RECEIVED
- 24 Oct 2019 — TEAS STATEMENT OF USE RECEIVED
- 13 May 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED